Cargando…
Phenotypes Associated With the Val122Ile, Leu58His, and Late-Onset Val30Met Variants in Patients With Hereditary Transthyretin Amyloidosis
BACKGROUND AND OBJECTIVES: Hereditary transthyretin amyloidosis (hATTR) is a rare autosomal dominant systemic disease with variable penetrance and heterogeneous clinical presentation. Several effective treatments can reduce mortality and disability, though diagnosis remains challenging, especially i...
Autores principales: | Zampino, Serena, Sheikh, Farooq H., Vaishnav, Joban, Judge, Daniel, Pan, Baohan, Daniel, Amrita, Brown, Emily, Ebenezer, Gigi, Polydefkis, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186220/ https://www.ncbi.nlm.nih.gov/pubmed/36941075 http://dx.doi.org/10.1212/WNL.0000000000207158 |
Ejemplares similares
-
Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015) -
Síncope como Expressão Fenotípica da Amiloidose Hereditária por Transtirretina Val142Ile (Val122Ile)
por: Nunes, Nágela S. V., et al.
Publicado: (2020) -
Molecular dynamics simulation study of AG10 and tafamidis binding to the Val122Ile transthyretin variant
por: Morris, Kevin F., et al.
Publicado: (2020) -
The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant
por: Perfetto, Federico, et al.
Publicado: (2015) -
Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis
por: Merlini, Giampaolo, et al.
Publicado: (2013)